All News #Library
Biotech
Galimedix Unveils Strong PK for Oral Alzheimer`s Drug at AD/PD
20 Mar 2026 //
GLOBENEWSWIRE
Galimedix To Present Next-Gen Oral Amyloid Beta Modulator Data
05 Mar 2026 //
GLOBENEWSWIRE
Galimedix Therapeutics Unveils Strong Phase 1 Results
04 Dec 2025 //
GLOBENEWSWIRE
Galimedix`s Alzheimer`s Oral Candidate Passes Phase 1 Safety Test
12 Sep 2025 //
FIERCE BIOTECH
Galimedix Completes Phase 1 Study for Alzheimer’s with GAL-101
12 Sep 2025 //
GLOBENEWSWIRE
Galimedix Completes Ph 1 SAD Trial Of GAL-101
06 May 2025 //
GLOBENEWSWIRE
Galimedix Therapeutics Initiates Phase 2 Study for GAL-101
23 Dec 2024 //
GLOBENEWSWIRE

Market Place
Sourcing Support